Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Choy

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Drugs|January 1, 1995
Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapiesE H Choy, D L Scott
Annals of the Rheumatic Diseases|September 11, 2007
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritisV Ravindran, D L Scott, E H Choy
The British Journal of Dermatology|September 22, 2016
Juvenile dermatomyositis: new clinical trial evidence to underpin therapeutic shared decision makingE D Owen, E H Choy, V Piguet
Clinical and Experimental Rheumatology|November 9, 2005
The consequences of rheumatoid arthritis: quality of life measures in the individual patientL Pollard, E H Choy, D L Scott
Clinical and Experimental Rheumatology|November 1, 1993
Indications for starting or changing disease modifying anti-rheumatic drugs in rheumatoid arthritis patientsG Yanni, E H Choy, G H Kingsley
British Journal of Rheumatology|August 1, 1995
Therapeutic monoclonal antibodiesE H Choy, G S Panayi, G H Kingsley
British Journal of Rheumatology|July 3, 1998
Monoclonal antibody therapy in rheumatoid arthritisE H Choy, G H Kingsley, G S Panayi
Arthritis and Rheumatism|May 1, 1993
Treatment with anti-CD4 monoclonal antibody and acute interstitial nephritisE H Choy, G H Kingsley, G S Panayi
Biological Signals and Receptors|November 27, 2001
Modulation of blood glucose by melatonin: a direct action on melatonin receptors in mouse hepatocytesA M Poon, E H Choy, S F Pang
Springer Seminars in Immunopathology|December 4, 1998
Anti-CD4 monoclonal antibodies in rheumatoid arthritisE H Choy, G H Kingsley, G S Panayi
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Drugs|January 1, 1995
Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapiesE H Choy, D L Scott
Annals of the Rheumatic Diseases|September 11, 2007
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritisV Ravindran, D L Scott, E H Choy
The British Journal of Dermatology|September 22, 2016
Juvenile dermatomyositis: new clinical trial evidence to underpin therapeutic shared decision makingE D Owen, E H Choy, V Piguet
Clinical and Experimental Rheumatology|November 9, 2005
The consequences of rheumatoid arthritis: quality of life measures in the individual patientL Pollard, E H Choy, D L Scott
Clinical and Experimental Rheumatology|November 1, 1993
Indications for starting or changing disease modifying anti-rheumatic drugs in rheumatoid arthritis patientsG Yanni, E H Choy, G H Kingsley
British Journal of Rheumatology|August 1, 1995
Therapeutic monoclonal antibodiesE H Choy, G S Panayi, G H Kingsley
British Journal of Rheumatology|July 3, 1998
Monoclonal antibody therapy in rheumatoid arthritisE H Choy, G H Kingsley, G S Panayi
Arthritis and Rheumatism|May 1, 1993
Treatment with anti-CD4 monoclonal antibody and acute interstitial nephritisE H Choy, G H Kingsley, G S Panayi
Biological Signals and Receptors|November 27, 2001
Modulation of blood glucose by melatonin: a direct action on melatonin receptors in mouse hepatocytesA M Poon, E H Choy, S F Pang
Springer Seminars in Immunopathology|December 4, 1998
Anti-CD4 monoclonal antibodies in rheumatoid arthritisE H Choy, G H Kingsley, G S Panayi
Pageof 6